Related Experiment Video
Updated: Oct 2, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Effect of cilazapril on insulin sensitivity in patients with essential arterial hypertension]
1Institute of Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade.
Abstract:
Insulin resistance is defined as a state with decreased insulin utilisation in peripheral tissues, despite of different plasma insulin values. Insulin resistance is one of the postulated pathophysiological mechanisms that participates in the development of essential hypertension. Hyperinsulinaemia is considered as a compensatory feature of insulin resistance. There way be a few possible mechanisms by which hyperinsulinaemia affects blood pressure. Another possibility is that insulin resistance per se, by some uncertain mechanisms, causes essential hypertension [1, 5]. We evaluated insulin sensitivity in 24 patients with mild-to-moderate essential hypertension before and after cilazapril monotherapy during 12 weeks. Insulin sensitivity (Si) was assessed by minimal model test (MINMOD) using frequently sampled intravenous glucose tolerance test in 0 week and after 12 weeks of treatment. After a 12-week cilazapril treatment insulin sensitivity significantly increased, while glucose efficacy was relatively unchanged.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...